KLRK1 and neoplasm: Furthermore, as described for Vγ9Vδ2 T cells, recognition of MICA, MICB, or ULBP expressed on cancer cells by human Vγ1δ1 T lymphocytes can trigger or increase their cytolytic activity against tumor cells that express NKG2D ligands (23, 96).